Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention
-
- Naveen L. Pereira
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota
-
- Michael E. Farkouh
- Peter Munk Cardiac Centre and Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, Ontario, Canada
-
- Derek So
- University of Ottawa Heart Institute, Ottawa, Ontario, Canada
-
- Ryan Lennon
- Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
-
- Nancy Geller
- National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
-
- Verghese Mathew
- Department of Medicine, Loyola University, Maywood, Illinois
-
- Malcolm Bell
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota
-
- Jang-Ho Bae
- Department of Internal Medicine, Division of Cardiology, Konyang University, Seo-gu, Taejon, South Korea
-
- Myung Ho Jeong
- Heart Research Center, Chonnam National University, Gwangju, South Korea
-
- Ivan Chavez
- Department of Cardiology, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota
-
- Paul Gordon
- Division of Cardiology, The Miriam Hospital, Providence, Rhode Island
-
- J. Dawn Abbott
- Division of Cardiology, Rhode Island Hospital, Providence, Rhode Island
-
- Charles Cagin
- Mayo Clinic Health System—La Crosse, La Crosse, Wisconsin
-
- Linnea Baudhuin
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
-
- Yi-Ping Fu
- National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
-
- Shaun G. Goodman
- St Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada
-
- Ahmed Hasan
- National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
-
- Erin Iturriaga
- National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
-
- Amir Lerman
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota
-
- Mandeep Sidhu
- Division of Cardiology, Department of Medicine, Albany Medical Center and Albany Medical College, Albany, New York
-
- Jean-Francois Tanguay
- Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada
-
- Liewei Wang
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota
-
- Richard Weinshilboum
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota
-
- Robert Welsh
- Department of Medicine, Mazankowski Alberta Heart Institute and University of Alberta, Edmonton, Alberta, Canada
-
- Yves Rosenberg
- National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
-
- Kent Bailey
- Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota
-
- Charanjit Rihal
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota
書誌事項
- タイトル別名
-
- The TAILOR-PCI Randomized Clinical Trial
収録刊行物
-
- JAMA
-
JAMA 324 (8), 761-, 2020-08-25
American Medical Association (AMA)